[Translation] A Phase I/II, open-label, multicenter study to evaluate the safety, tolerability, pharmacokinetic profile, and antitumor efficacy of GW5282 in subjects with non-Hodgkin lymphoma (BEI-DOU1)
评估GW5282在非霍奇金淋巴瘤受试者中的安全性、耐受性、药代动力学特征和抗肿瘤疗效
[Translation] To evaluate the safety, tolerability, pharmacokinetic profile and anti-tumor efficacy of GW5282 in subjects with non-Hodgkin's lymphoma